Rohto Pharmaceutical Co.L... (RPHCF)

AI Score

Unlock

20.09

-6.54 (-24.56%)

At close: Jan 24, 2025, 8:00 PM

Rohto Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	69.68B	519.43M	446.34M	423.79M	469.69M	502.8M	401.01M	384.81M	456.95M	460.38M	437.56M	381.25M	465M	46.62B	44.28B	38.77B	50.36B	47.64B	48.53B	41.85B	48.99B	47.47B	46.58B	40.64B	47.79B	45.57B	42.54B	35.9B	43.24B	40.04B	38.35B	32.97B	46.28B	42.91B	41.82B	35.46B
Cost of Revenue	29.81B	212.11M	191.43M	176.68M	199.55M	206.54M	174.54M	167.56M	190.3M	187.9M	184.16M	165.03M	193.88M	18.86B	17.63B	16.71B	18.96B	18.36B	19.26B	17.55B	19.55B	19.21B	18.55B	16.73B	19.26B	18.29B	17.52B	15.69B	17.17B	16.29B	15.44B	14.34B	18.51B	16.94B	16.71B	15.09B
Gross Profit	39.87B	307.32M	254.91M	247.11M	270.14M	296.26M	226.47M	217.25M	266.65M	272.48M	253.39M	216.22M	271.11M	27.75B	26.65B	22.06B	31.4B	29.28B	29.27B	24.3B	29.43B	28.25B	28.03B	23.91B	28.53B	27.29B	25.02B	20.21B	26.06B	23.75B	22.91B	18.63B	27.77B	25.97B	25.11B	20.37B
Operating Income	4.79B	101.32M	63.09M	79.94M	40.36M	94M	53.65M	61.08M	46.56M	84.06M	64.11M	54.14M	46.04M	6.28B	6.9B	3.58B	4.96B	7.73B	6.53B	3.86B	3.62B	6.48B	5.65B	5.06B	3.48B	6.95B	5.22B	3.43B	3.06B	5.93B	4.25B	2.22B	3.82B	4.69B	5.32B	1.86B
Interest Income	428M	3M	2.38M	2.19M	2.4M	1.62M	1.23M	1.86M	764K	903.34K	871.45K	666.73K	733.03K	76M	91M	93M	113M	133M	125M	113M	110M	91M	99M	77M	176M	63M	60M	55M	72M	39M	50M	47M	60M	59M	84M	61M
Pretax Income	4.95B	99.4M	68.94M	84.81M	35.85M	89.33M	56.33M	71.1M	36.18M	84.33M	66.74M	57.76M	54.14M	7.97B	6.06B	2.69B	2.77B	8.48B	7.29B	3.18B	-263M	5.99B	5.48B	5.09B	1.61B	6.93B	4.77B	3.52B	2.54B	6.09B	4.13B	2B	2.55B	4.52B	5.12B	2.11B
Net Income	4.78B	67.77M	50.22M	62.98M	35.67M	64.39M	42.81M	51.5M	33.56M	53.65M	54.14M	42.63M	51.21M	4.91B	4.24B	1.75B	2.85B	5.26B	5.09B	2.22B	-1.07B	3.55B	3.88B	3.44B	-813M	4.46B	3.37B	2.27B	1.6B	4.22B	2.82B	1.37B	1.29B	2.93B	3.54B	1.33B
Selling & General & Admin	n/a	186.46M	170.7M	149.8M	203.67M	184.97M	151.23M	139.59M	199.07M	171.57M	167.82M	145.01M	204.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	n/a	19.54M	21.12M	17.37M	26.12M	17.3M	21.59M	16.57M	21.02M	16.84M	21.46M	17.06M	20.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	35.08B	263M	252M	180M	-355M	-510M	288M	514M	-52M	144M	36M	118M	-0.00	36M	-58M	134M	-324M	65M	135M	91M	-17M	-101M	62M	18M	-27M	-33M	27M	133M	22M	21M	93M	67M	-160M	-8M	51M	-2M
Operating Expenses	35.08B	206M	191.82M	167.17M	229.78M	202.26M	172.82M	156.16M	220.09M	188.42M	189.28M	162.08M	225.08M	21.47B	19.75B	18.49B	26.96B	21.55B	22.73B	20.44B	25.81B	21.77B	22.38B	18.85B	25.04B	20.34B	19.8B	16.78B	23B	17.82B	18.66B	16.41B	23.95B	21.29B	19.8B	18.51B
Interest Expense	16M	503.18K	421.6K	318.69K	398.93K	541.3K	455.86K	419.75K	1.07M	390.87K	368.34K	288.31K	434.39K	32M	33M	32M	30M	31M	31M	33M	39M	41M	39M	29M	42M	32M	37M	32M	36M	33M	33M	33M	35M	43M	44M	44M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	46.47B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	64.89B	418.11M	383.25M	343.85M	429.33M	408.81M	347.36M	323.72M	410.39M	376.32M	373.45M	327.11M	418.96M	40.34B	37.38B	35.2B	45.92B	39.91B	41.99B	37.99B	45.36B	40.98B	40.93B	35.58B	44.3B	38.62B	37.32B	32.46B	40.17B	34.12B	34.1B	30.75B	42.46B	38.23B	36.51B	33.6B
Income Tax Expense	84M	30.62M	18.26M	20.71M	1.26M	24.14M	13.38M	19.07M	2.89M	29.62M	12.4M	14.97M	2.8M	3.06B	1.82B	933M	95M	3.2B	2.19B	959M	829M	2.42B	1.59B	1.64B	2.37B	2.48B	1.4B	1.24B	940M	1.86B	1.31B	628M	1.26B	1.59B	1.57B	787M
Shares Outstanding (Basic)	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	228.14M	n/a	n/a	228.14M	n/a	n/a	n/a	227.94M	n/a	n/a	n/a	227.86M	n/a	n/a	n/a	227.83M	n/a	n/a	n/a	227.53M	n/a	n/a	n/a	227.22M
Shares Outstanding (Diluted)	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	228.8M	n/a	n/a	228.81M	n/a	n/a	n/a	228.79M	n/a	n/a	n/a	228.8M	n/a	n/a	n/a	228.76M	n/a	n/a	n/a	228.45M	n/a	n/a	n/a	228.18M
EPS (Basic)	20.95	0.30	0.22	0.28	0.16	0.28	0.19	0.23	0.15	0.24	0.24	0.19	0.22	n/a	n/a	7.66	n/a	n/a	n/a	9.73	n/a	n/a	n/a	15.10	n/a	n/a	n/a	9.99	n/a	n/a	n/a	6.04	n/a	n/a	n/a	5.85
EPS (Diluted)	20.89	0.30	0.22	0.28	0.16	0.28	0.19	0.23	0.15	0.23	0.24	0.19	0.22	n/a	n/a	7.64	n/a	n/a	n/a	9.69	n/a	n/a	n/a	15.04	n/a	n/a	n/a	9.95	n/a	n/a	n/a	6.01	n/a	n/a	n/a	5.82
EBITDA	4.96B	14.1B	10.37B	12.29B	4.82B	11.79B	8.22B	9.71B	4.53B	9.75B	7.47B	6.46B	6.03B	6.43B	7.15B	3.97B	4.16B	7.22B	6.99B	3.96B	1.39B	6.53B	5.88B	5.12B	3.14B	7.03B	5.19B	3.63B	3.03B	6.18B	4.42B	2.46B	2.59B	4.56B	5.17B	2.15B
EBIT	4.96B	14.1B	10.37B	12.29B	4.82B	11.79B	8.22B	9.71B	4.53B	9.75B	7.47B	6.46B	6.03B	8.01B	6.09B	2.72B	2.8B	8.52B	7.33B	3.22B	-224M	6.04B	5.52B	5.12B	1.65B	6.96B	4.81B	3.55B	2.57B	6.13B	4.16B	2.03B	2.59B	4.56B	5.17B	2.15B
Depreciation & Amortization	342M	15.47M	14.13M	43.28K	43.81K	-39.59K	122.08K	41.58K	54.88K	27.08K	86.06K	60.46K	71.39K	54K	55.81K	55.21K	55.13K	52.75K	51.12K	47.3K	46.47K	44.65K	40.96K	40.37K	-343M	78M	-28M	196M	-27M	251M	175M	247M	-673M	69M	87M	337M